GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alnylam Pharmaceuticals, Inc. (ALNY) [hlAlert]

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with
small molecules or antibodies, the current major classes of drugs. Alnylam is building a pipeline of RNAi therapeutics; its lead program is in Phase I human clinical trials for the treatment of respiratory syncytial virus infection, which is the leading cause of hospitalization in infants in the U.S. The company's leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, and Biogen Idec.
( Total: 14 Current Stock Recommendations )
Alnylam Pharmaceuticals, Inc.   (14)
Hold 29% Buy 71%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Show  

Date (ET)MemberRatingYTD
Gains
 
2/11/2013  
Hold
  
5/6/2011  
Buy
  
1/17/2014  
Buy
  
5/20/2010  
Buy
  
1/14/2014  
Hold
  
11/17/2014  
Buy
  
7/14/2009  
Hold
  
10/14/2011  
Buy
  
2/8/2008  
Buy
  
12/5/2007  
Buy
  
11/24/2009  
Hold
  
8/31/2015  
Buy
  
2/8/2013  
Buy
  
6/10/2009  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy